Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Data presented for factor XIa inhibitor milvexian in thrombosis models

Aug. 4, 2020

Src SH3 domain: an antithrombotic target without compromising homeostasis

July 31, 2020

Novel mouse model of AAA with intraluminal thrombus

July 30, 2020

INSERM presents preclinical data for single-domain antibody PS-003

July 28, 2020

FRSW-107 demonstrates extended half-life in patients with hemophilia A

July 28, 2020

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

July 27, 2020

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

July 27, 2020

MPI-8 reduces thrombosis without increased bleeding in vivo

July 27, 2020

In vivo studies show potent reversal of anticoagulation with VMX-COO1

July 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.